Views: 35 Author: Site Editor Publish Time: 2026-03-27 Origin: Site
In diabetes management, HbA1c is considered the gold standard. However, for patients with complex hemoglobin variants (e.g., HbS, HbE) or in regions with a high prevalence of thalassemia, traditional testing methods often yield inaccurate results. How can laboratories balance high-throughput demands with diagnostic accuracy?
Many labs using immunoassay or enzymatic methods encounter discrepancies between clinical results and patient glucose levels. This is often due to variant interference.
Challenge: Variants can alter the hemoglobin structure, causing false elevations or depressions in non-HPLC methods.
Medlere Solution: The Medlere M3 utilizes ion-exchange High-Performance Liquid Chromatography (HPLC) technology. Through precise charge separation, the M3 not only calculates HbA1c but also clearly identifies common variants like HbS, HbC, HbD, HbE in the chromatogram. This means physicians receive a clear chromatographic profile — not just a single numerical result.
A major challenge is that traditional HbA1c tests can't provide HbF (fetal hemoglobin) data. In many regions with high thalassemia prevalence, early screening is crucial.
Medlere Solution: The M3 concurrently screens for HbF elevation while performing the HbA1c test. This provides immense added value to the laboratory: offering screening clues for suspected thalassemia patients during routine diabetes checks, achieving true "multi-use for one machine."
Manual cap removal is slow and increases biohazard exposure risk. High-volume lab demands require modern safety and efficiency.
Medlere Solution: The M3 features fully automated operation with integrated cap-piercing technology
Safety: No manual decapping required; the sampling process is closed and secure.
Convenience: Primary tubes sample directly on board, supporting both whole blood and capillary blood.
Efficiency: From sampling to results in less than 120 seconds, well-suited to the workflow of small to mid-sized laboratories.
Equipment stability is key, especially in regions where operational costs are critical.
Medlere Advantage: For our partners, we optimize reagent consumption. The M3 requires minimal daily calibration and quality control (CV ≤ 3%). Built to UK engineering standards, it ensures long component lifespan (e.g., dual-piston high-pressure pumps), reducing total cost of ownership.
In this rapidly evolving diagnostic landscape, Medlere provides not just an M3 HbA1c Analyzer, but a complete clinical solution covering precise diagnosis, safe operation, and added value.
Ready to optimize your laboratory workflow? [Contact our professional team to receive the details info@medlere.com]
